Isaac Cheng - Net Worth and Insider Trading
Isaac Cheng Net Worth
The estimated net worth of Isaac Cheng is at least $30 Million dollars as of 2024-09-20. Isaac Cheng is the Director of Amylyx Pharmaceuticals Inc and owns about 10,422,228 shares of Amylyx Pharmaceuticals Inc (AMLX) stock worth over $30 Million. Details can be seen in Isaac Cheng's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Isaac Cheng has not made any transactions after 2022-01-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Isaac Cheng
Isaac Cheng Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Isaac Cheng owns 2 companies in total, including Atea Pharmaceuticals Inc (AVIR) , and Amylyx Pharmaceuticals Inc (AMLX) .
Click here to see the complete history of Isaac Cheng’s form 4 insider trades.
Insider Ownership Summary of Isaac Cheng
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVIR | Atea Pharmaceuticals Inc | 2020-10-29 | director |
| AMLX | Amylyx Pharmaceuticals Inc | 2022-01-06 | director |
Isaac Cheng Latest Holdings Summary
Isaac Cheng currently owns a total of 1 stock. Isaac Cheng owns 10,422,228 shares of Amylyx Pharmaceuticals Inc (AMLX) as of January 6, 2022, with a value of $30 Million.
Latest Holdings of Isaac Cheng
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals Inc | 2022-01-06 | 10,422,228 | 2.88 | 30,016,017 |
Holding Weightings of Isaac Cheng
Isaac Cheng Form 4 Trading Tracker
According to the SEC Form 4 filings, Isaac Cheng has made a total of 1 transactions in Amylyx Pharmaceuticals Inc (AMLX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Amylyx Pharmaceuticals Inc is the acquisition of 6,578 shares on January 6, 2022, which cost Isaac Cheng around $124,982.
Insider Trading History of Isaac Cheng
- 1
Isaac Cheng Trading Performance
Isaac Cheng Ownership Network
Isaac Cheng Owned Company Details
What does Atea Pharmaceuticals Inc do?
Who are the key executives at Atea Pharmaceuticals Inc?
Isaac Cheng is the director of Atea Pharmaceuticals Inc. Other key executives at Atea Pharmaceuticals Inc include director & 10 percent owner & President & CEO & and Chairman Jean-pierre Sommadossi , See Remarks Andrea Corcoran , and See Remarks Wayne Foster .
Atea Pharmaceuticals Inc (AVIR) Insider Trades Summary
Over the past 18 months, Isaac Cheng made no insider transaction in Atea Pharmaceuticals Inc (AVIR). Other recent insider transactions involving Atea Pharmaceuticals Inc (AVIR) include a net sale of 115,885 shares made by Jean-pierre Sommadossi , a net sale of 17,544 shares made by Bruce Polsky , and a net sale of 15,870 shares made by Maria Arantxa Horga .
In summary, during the past 3 months, insiders sold 57,969 shares of Atea Pharmaceuticals Inc (AVIR) in total and bought 0 shares, with a net sale of 57,969 shares. During the past 18 months, 203,467 shares of Atea Pharmaceuticals Inc (AVIR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 203,467 shares.
Atea Pharmaceuticals Inc (AVIR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atea Pharmaceuticals Inc Insider Transactions
Isaac Cheng Mailing Address
Above is the net worth, insider trading, and ownership report for Isaac Cheng. You might contact Isaac Cheng via mailing address: C/o Atea Pharmaceuticals, Inc., 125 Summer Street, Boston Ma 02110.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
